-
Our portfolio companies are a top priority.
We finance new therapies and medical technologies to improve patient outcomes and build value for investors.
-

“TVM has not just provided the capital to accelerate our growth, but they also bring a wealth of experience and top-notch advisors who add value across the operational spectrum.”
Pierre Lemire, CEO, Kent Imaging
Home > Portfolio


























